Ironwood Pharmaceuticals
Commercial-stage biopharmaceutical company focused on GI diseases, known for LINZESS (linaclotide) for irritable bowel syndrome and chronic constipation. Publicly traded on NASDAQ (IRWD).
Location
Boston, Massachusetts, USA
Founded
1998
Investors
1
Categories
pharmaceuticals, gastrointestinal, therapeutics, public
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |